Pharmafile Logo
- PMLiVE

Pharmaceutical Market Europe – April 2018

In this month’s PME Dr Peter Jackson from the AMR Centre, which plays a key role in the UK’s response, gives us a rundown on the state of antimicrobial resistance...

- PMLiVE

Pharmaceutical Market Europe – March 2018

Pharma’s transition continues apace, as the real, game-changing innovation it creates in areas such as cancer and hepatitis sees the question of how to reward these advances become evermore pressing.

- PMLiVE

Pharmaceutical Market Europe – February 2018

In this month’s PME there's insight from UCB, Insmed and Merck

- PMLiVE

Pharmaceutical Market Europe – January 2018

As a new year begins, and you review your plans for 2018, PME this month fastens its seatbelt for a timely look at strategic planning.

- PMLiVE

Pharmaceutical Market Europe – December 2017

In PME’s last issue for 2017 we look at marketing excellence, HTA and PMEA 2017

- PMLiVE

Pharmaceutical Market Europe – November 2017

In the November issue of PME behaviour change looms large, with Sanofi’s global head of patient solutions Dr Anne Beal talking to us about the company’s new behavioural science advisory...

- PMLiVE

Pharmaceutical Market Europe – October 2017

In the October issue of PME we look at pharma’s measured progress with multichannel marketing, how the nature of competition is changing and hear from Janssen’s Johan van Hoof

- PMLiVE

Pharmaceutical Market Europe – September 2017

From Brexit to European elections to strategic planning, change figures highly in this month's PME

- PMLiVE

Pharmaceutical Market Europe – July/August 2017

European regulatory change, applying artificial intelligence to drug deveopment and healthy old age all feature in this issue

- PMLiVE

Pharmaceutical Market Europe – June 2017

June's PME covers Germany's pharma market, digital disruption and European versus US approval rates

- PMLiVE

Pharmaceutical Market Europe – May 2017

In the May issue of PME we look at patient engagement and hear how some of the structural barriers within the industry are working against some of its initiatives

- PMLiVE

Pharmaceutical Market Europe – April 2017

As Brexit begins, the April issue of PME offers advice on what pharma should do next and how the likely timelines shapeup